Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Perrin

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Cancer Medicine|December 20, 2022
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma groupMehdi Brahmi, Nathalie Gaspar, Justine Gantzer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2021
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II studyFlorence Duffaud, Antoine Italiano, Emannuelle Bompas, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2026
Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma groupEva Kalfala, Alexandra Meurgey, Clémence Hénon, et al.
Breast (Edinburgh, Scotland)|May 8, 2020
Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohortSophie Frank, Matthieu Carton, Coraline Dubot, et al.
The New England Journal of Medicine|December 12, 2019
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast CancerShanu Modi, Cristina Saura, Toshinari Yamashita, et al.
Breast (Edinburgh, Scotland)|October 8, 2021
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME databaseMylène Annonay, Lisa Gauquelin, Romain Geiss, et al.
Diabetes|May 28, 2005
The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoformGema Medina-Gomez, Sam Virtue, Christopher Lelliott, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2013
Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogensColette Cywes-Bentley, David Skurnik, Tanweer Zaidi, et al.
Anticancer Research|July 5, 2020
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC StudyPierre Heudel, Suzette Delaloge, Damien Parent, et al.
The Lancet. Oncology|October 19, 2016
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trialOlivier Mir, Thomas Brodowicz, Antoine Italiano, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Cancer Medicine|December 20, 2022
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma groupMehdi Brahmi, Nathalie Gaspar, Justine Gantzer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2021
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II studyFlorence Duffaud, Antoine Italiano, Emannuelle Bompas, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2026
Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma groupEva Kalfala, Alexandra Meurgey, Clémence Hénon, et al.
Breast (Edinburgh, Scotland)|May 8, 2020
Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohortSophie Frank, Matthieu Carton, Coraline Dubot, et al.
The New England Journal of Medicine|December 12, 2019
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast CancerShanu Modi, Cristina Saura, Toshinari Yamashita, et al.
Breast (Edinburgh, Scotland)|October 8, 2021
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME databaseMylène Annonay, Lisa Gauquelin, Romain Geiss, et al.
Diabetes|May 28, 2005
The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoformGema Medina-Gomez, Sam Virtue, Christopher Lelliott, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2013
Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogensColette Cywes-Bentley, David Skurnik, Tanweer Zaidi, et al.
Anticancer Research|July 5, 2020
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC StudyPierre Heudel, Suzette Delaloge, Damien Parent, et al.
The Lancet. Oncology|October 19, 2016
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trialOlivier Mir, Thomas Brodowicz, Antoine Italiano, et al.
Pageof 15